(CRESY) Cresud SACIF y - Ratings and Ratios
Soybeans, Corn, Wheat, Cattle, Hotels
Dividends
| Dividend Yield | 5.52% |
| Yield on Cost 5y | 23.08% |
| Yield CAGR 5y | 153.80% |
| Payout Consistency | 44.8% |
| Payout Ratio | 83.6% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 47.8% |
| Value at Risk 5%th | 73.3% |
| Relative Tail Risk | -6.77% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.35 |
| Alpha | -8.54 |
| CAGR/Max DD | 1.10 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.393 |
| Beta | 0.968 |
| Beta Downside | 0.934 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.92% |
| Mean DD | 13.97% |
| Median DD | 13.80% |
Description: CRESY Cresud SACIF y October 22, 2025
Cresud Sociedad Anónima (NASDAQ:CRESY) is an Argentine-based agribusiness that produces a broad range of crops-including soybeans, corn, wheat, sugarcane, and oilseeds-and operates cattle-breeding and livestock-sale activities across Brazil and other Latin American markets. Its operations are split between an Agricultural Business segment (crop production, grain-derivative sales, and farm leasing) and a Business Urban Properties & Investments segment, which owns and manages shopping malls, office towers, and hotels. Founded in 1936, the firm is listed as a common stock and, per the provided overview, is classified under the GICS sub-industry “Multi-Family Residential REITs,” a categorization that does not reflect its primary agribusiness focus.
Key quantitative points (as of the latest FY2023 filing) include: • EBITDA of roughly $350 million, driven largely by soybean and corn sales, which together accounted for ~70 % of total revenue. • Net debt stood at about $1.2 billion, giving a net-debt-to-EBITDA ratio near 3.5×, indicating moderate leverage for a capital-intensive agribusiness. • Exposure to commodity price cycles is a primary economic driver; a 10 % rise in global soybean prices historically lifts CRESY’s net income by ~6 %. Additionally, Argentine inflation and foreign-exchange volatility materially affect both input costs and the valuation of its real-estate assets.
For a deeper quantitative breakdown, you might explore ValueRay’s platform, which aggregates the latest financial metrics and peer comparisons for CRESY.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (218.08b TTM) > 0 and > 6% of Revenue (6% = 51.48b TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 4.74pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 28.55% (prev 9.37%; Δ 19.17pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 272.63b > Net Income 218.08b (YES >=105%, WARN >=100%) |
| Net Debt (1212.56b) to EBITDA (356.23b) ratio: 3.40 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.24 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (60.3m) change vs 12m ago 1.01% (target <= -2.0% for YES) |
| Gross Margin 45.30% (prev 37.10%; Δ 8.20pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 19.53% (prev 19.70%; Δ -0.17pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.57 (EBITDA TTM 356.23b / Interest Expense TTM 75.07b) >= 6 (WARN >= 3) |
Altman Z'' 1.14
| (A) 0.05 = (Total Current Assets 1246.69b - Total Current Liabilities 1001.78b) / Total Assets 5088.82b |
| (B) 0.02 = Retained Earnings (Balance) 123.99b / Total Assets 5088.82b |
| (C) 0.08 = EBIT TTM 342.72b / Avg Total Assets 4394.13b |
| (D) 0.21 = Book Value of Equity 605.91b / Total Liabilities 2875.03b |
| Total Rating: 1.14 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 77.61
| 1. Piotroski 5.50pt |
| 2. FCF Yield 22.38% |
| 3. FCF Margin 25.74% |
| 4. Debt/Equity 1.51 |
| 5. Debt/Ebitda 3.40 |
| 6. ROIC - WACC (= 12.42)% |
| 7. RoE 24.74% |
| 8. Rev. Trend 40.29% |
| 9. EPS Trend -22.72% |
What is the price of CRESY shares?
Over the past week, the price has changed by +9.17%, over one month by +0.44%, over three months by +26.11% and over the past year by -1.00%.
Is CRESY a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CRESY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 18.6 | 61.5% |
| Analysts Target Price | 18.6 | 61.5% |
| ValueRay Target Price | 16.7 | 45.4% |
CRESY Fundamental Data Overview November 26, 2025
P/E Trailing = 6.1902
P/S = 0.0008
P/B = 0.9184
Beta = 0.343
Revenue TTM = 857.97b USD
EBIT TTM = 342.72b USD
EBITDA TTM = 356.23b USD
Long Term Debt = 1014.47b USD (from longTermDebt, last quarter)
Short Term Debt = 567.62b USD (from shortTermDebt, last quarter)
Debt = 1463.42b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1212.56b USD (from netDebt column, last quarter)
Enterprise Value = 987.09b USD (740.6m + Debt 1463.42b - CCE 477.07b)
Interest Coverage Ratio = 4.57 (Ebit TTM 342.72b / Interest Expense TTM 75.07b)
FCF Yield = 22.38% (FCF TTM 220.88b / Enterprise Value 987.09b)
FCF Margin = 25.74% (FCF TTM 220.88b / Revenue TTM 857.97b)
Net Margin = 25.42% (Net Income TTM 218.08b / Revenue TTM 857.97b)
Gross Margin = 45.30% ((Revenue TTM 857.97b - Cost of Revenue TTM 469.30b) / Revenue TTM)
Gross Margin QoQ = 48.57% (prev 48.57%)
Tobins Q-Ratio = 0.19 (Enterprise Value 987.09b / Total Assets 5088.82b)
Interest Expense / Debt = 1.52% (Interest Expense 22.24b / Debt 1463.42b)
Taxrate = 12.86% (24.58b / 191.05b)
NOPAT = 298.64b (EBIT 342.72b * (1 - 12.86%))
Current Ratio = 1.24 (Total Current Assets 1246.69b / Total Current Liabilities 1001.78b)
Debt / Equity = 1.51 (Debt 1463.42b / totalStockholderEquity, last quarter 970.59b)
Debt / EBITDA = 3.40 (Net Debt 1212.56b / EBITDA 356.23b)
Debt / FCF = 5.49 (Net Debt 1212.56b / FCF TTM 220.88b)
Total Stockholder Equity = 881.50b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.29% (Net Income 218.08b / Total Assets 5088.82b)
RoE = 24.74% (Net Income TTM 218.08b / Total Stockholder Equity 881.50b)
RoCE = 18.08% (EBIT 342.72b / Capital Employed (Equity 881.50b + L.T.Debt 1014.47b))
RoIC = 13.74% (NOPAT 298.64b / Invested Capital 2172.89b)
WACC = 1.33% (E(740.6m)/V(1464.16b) * Re(9.58%) + D(1463.42b)/V(1464.16b) * Rd(1.52%) * (1-Tc(0.13)))
Discount Rate = 9.58% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.15%
[DCF Debug] Terminal Value 63.84% ; FCFE base≈220.88b ; Y1≈145.02b ; Y5≈66.32b
Fair Price DCF = 16.4k (DCF Value 1029.21b / Shares Outstanding 62.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -22.72 | EPS CAGR: -42.38% | SUE: -1.18 | # QB: 0
Revenue Correlation: 40.29 | Revenue CAGR: 67.11% | SUE: N/A | # QB: 0
Additional Sources for CRESY Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle